Clinical Trial Update: Treatment of Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 clinical trial evaluating an investigational therapy for moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Investigational therapy

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED